AAAAAA

   
Results: 1-19 |
Results: 19

Authors: Marriott, JB Muller, G Stirling, D Dalgleish, AG
Citation: Jb. Marriott et al., Immunotherapeutic and antitumour potential of thalidomide analogues, EXPERT OP B, 1(4), 2001, pp. 675-682

Authors: Cairns, GR Cross, RJ Stirling, D
Citation: Gr. Cairns et al., Characterisation of catalysts and their precursors prepared from supportedpalladium phosphine complexes, J MOL CAT A, 172(1-2), 2001, pp. 207-218

Authors: Crilly, A Bartlett, JMS White, A Stirling, D Capell, H Madhok, R
Citation: A. Crilly et al., Investigation of novel polymorphisms within the 3 ' region of the IL-6 gene in patients with rheumatoid arthritis using Genescan analysis, CYTOKINE, 13(2), 2001, pp. 109-112

Authors: Suzuki, T Mackenzie, L Stirling, D Adamson, J
Citation: T. Suzuki et al., Conversion of pectenotoxin-2 to pectenotoxin-2 seco acid in the New Zealand scallop, Pecten novaezelandiae, FISHERIES S, 67(3), 2001, pp. 506-510

Authors: Stirling, D
Citation: D. Stirling, Thalidomide: A novel template for anticancer drugs, SEMIN ONCOL, 28(6), 2001, pp. 602-606

Authors: Suzuki, T Mackenzie, L Stirling, D Adamson, J
Citation: T. Suzuki et al., Pectenotoxin-2 seco acid: a toxin converted from pectenotoxin-2 by the NewZealand Greenshell mussel, Perna canaliculus, TOXICON, 39(4), 2001, pp. 507-514

Authors: Kerr, R Stirling, D Ludlam, CA
Citation: R. Kerr et al., Interleukin 6 and haemostasis, BR J HAEM, 115(1), 2001, pp. 3-12

Authors: Wu, ZP Liu, J Stirling, D
Citation: Zp. Wu et al., Determination of physicochemical properties in drug discovery and development, FRONTIERS OF BIOTECHNOLOGY & PHARMACEUTICALS, VOL 2, 2001, pp. 176-188

Authors: Teo, S Evans, M Ehrhart, J Brockman, M Allen, D Morgan, M Stirling, D Thomas, S
Citation: S. Teo et al., Lack of peripheral neuropathy in Beagle dogs after 53 weeks oral administration of thalidomide capsules, HUM EXP TOX, 19(11), 2000, pp. 615-622

Authors: Kaplan, G Thomas, S Fierer, DS Mulligan, K Haslett, PAJ Fessel, WJ Smith, LG Kook, KA Stirling, D Schambelan, M
Citation: G. Kaplan et al., Thalidomide for the treatment of AIDS-associated wasting, AIDS RES H, 16(14), 2000, pp. 1345-1355

Authors: Teo, S Morgan, M Stirling, D Thomas, S
Citation: S. Teo et al., Assessment of the in vitro and in vivo genotoxicity of Thalomid (R) (Thalidomide), TER CAR MUT, 20(5), 2000, pp. 301-311

Authors: Cross, RJ Newman, PD Peacock, RD Stirling, D
Citation: Rj. Cross et al., Chiral phosphinoylalcohol complexes of monooxobis(peroxo)molybdenum(VI) and their use as asymmetric oxidants, J MOL CAT A, 144(2), 1999, pp. 273-284

Authors: Baird, T Campbell, KC Holliman, PJ Hoyle, RW Huxam, M Stirling, D Williams, BP Morris, M
Citation: T. Baird et al., Cobalt-zinc oxide absorbents for low temperature gas desulfurisation, J MAT CHEM, 9(2), 1999, pp. 599-605

Authors: Fewtrell, MS Prentice, A Jones, SC Bishop, NJ Stirling, D Buffenstein, R Lunt, M Cole, TJ Lucas, A
Citation: Ms. Fewtrell et al., Bone mineralization and turnover in preterm infants at 8-12 years of age: The effect of early diet, J BONE MIN, 14(5), 1999, pp. 810-820

Authors: Stirling, D Duncan, AM Guest, JE Finch, AA
Citation: D. Stirling et al., Petrogenesis of plagioclase phenocrysts of Mount Etna, Sicily, with particular reference to the 1983 eruption: contribution from cathodoluminescence petrography, MINERAL MAG, 63(2), 1999, pp. 189

Authors: Cross, RJ Farrugia, LJ Newman, PD Peacock, RD Stirling, D
Citation: Rj. Cross et al., Metal complexes of new, chiral N2O2 tetradentate ligands, INORG CHEM, 38(6), 1999, pp. 1186-1192

Authors: Pearson, HJL Stirling, D Ludlam, CA Steel, CM
Citation: Hjl. Pearson et al., TGF-beta is not the principal immunosuppressive component in coagulation factor concentrates, BR J HAEM, 106(4), 1999, pp. 971-979

Authors: Macleod, N Fryer, JR Stirling, D Webb, G
Citation: N. Macleod et al., Deactivation of bi- and multimetallic reforming catalysts: influence of alloy formation on catalyst activity, CATAL TODAY, 46(1), 1998, pp. 37-54

Authors: Bunce, S Cross, RJ Farrugia, LJ Kunchandy, S Meason, LL Muir, KW O'Donnell, M Peacock, RD Stirling, D Teat, SJ
Citation: S. Bunce et al., Chiral Schiff base complexes of copper(II), vanadium(IV) and nickel(II) asoxidation catalysts. X-ray crystal structures of [Cu(R-salpn)(OH2)] and [Cu(+/--busalcx)], POLYHEDRON, 17(23-24), 1998, pp. 4179-4187
Risultati: 1-19 |